Post #ISSCR2025 product highlight series by LAB-A-PORTER
GeneTex: Antibodies against cell markers for detection in disease modelling
The journey from basic discoveries to clinical applications is often hampered by issues of reproducibility, predictability, and clinical relevance. Building robust in vitro and in vivo studies is essential for validating preclinical findings and ensuring their successful translation.
LAB-A-PORTER is committed to facilitating this by providing researchers globally with suitable reagents and tools. We support researchers on their preclinical research, from discovering drug targets and biomarkers to developing and testing in advanced in vitro and animal models, ultimately helping bridge the gap to clinical success.
In the following weeks, LAB-A-PORTER is going to showcase a series of products that have been highlighted in our booth at ISSCR 2025 Hong Kong, including tools for disease modelling, drug discovery, cell and gene therapy research and tissue engineering research.
This week, we are going to introduce one of our trusted supplier, GeneTex, and their quality antibodies against cell markers for detection in disease modelling.
GeneTex: Antibodies against cell markers for detection in disease modelling
Cell markers are biochemical or genetic characteristics that distinguish and discriminate between different cell types. Although most are molecules expressed on the plasma membrane, cell markers are not limited to surface antigens and can include other components such as transcription factors. The unique composition and combination of cell markers allows researchers to accurately delineate the various cell types within a population. As the fields of regenerative medicine and molecular diagnostics continue to expand, the need to discover and describe novel cell-specific markers will become even more urgent.
GeneTex offer antibodies against cell markers for detection, including stem cell markers, neural markers, markers for smooth muscle cells, epithelial cells, tumor markers and more.
Download flyer now to explore more or click to learn more about GeneTex’s comprehensive offering on antibodies for research on cancer research.
ABOUT GENETEX
With a 27-year production history, GeneTex continues to distinguish itself by emphasizing reagent validation.
Founded by scientists for scientists, GeneTex understands that researchers expect and demand product fidelity.
With a 27-year production history, GeneTex distinguishes itself by emphasising reagent validation. Poorly characterized antibodies remain an industry-wide challenge that impacts progress in the life sciences and biomedicine.
At GeneTex, product reliability is their primary concern. Stringent protocols have been established to validate their antibodies for various applications, including WB, IP, IHC, ICC/IF, FACS, and ELISA, using cell lines with known target protein expression levels and a diverse array of tissue samples. Lot-to-lot antibody performance is maintained through a combination of fully characterized reference lots, clone verification, and thorough quality control.
GeneTex products are made to standards outlined in quality management systems ISO 9001:2015, ISO 13485:2016 and ISO 14001: 2015.
All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.